Associate Program Director, Yale MD-PhD Program, Director, Regional Liver Cancer Program, VA VISN1 (Southern New England)

Professor of Internal Medicine (Digestive Diseases)

Dr Taddei has long been associated with Yale’s Gaucher program. Having published seminal articles on the natural history of N370S mutation-related Gaucher disease, in which she described an increased risk of bone disease and cancers, especially multiple myeloma in older adults.

Additionally, Dr Taddie conducted an important study on the increased risk of cholesterol gallstones. The study showed altered bile composition in Gaucher disease in a manner that caused precipitation of cholesterol crystals in bile. Dr Taddei showed gallstones in Gaucher disease caused increased symptoms leading to gallbladder surgery, and it was associated with low levels of ‘good cholesterol (HDL).

Passionate about educating, mentoring and sponsoring the next generation, Dr Taddei has been recognized with teaching awards for her dedication to the education and career advancement of medical students, residents, and fellows. Currently, Dr Taddei is mentoring Lysosomal Disease Fellow Dr Mohsen Basiri in a study showing the increased risk of liver cancer in Gaucher disease.

Education and training

● Fellow - Yale University School of Medicine (2007)

● Resident- Georgetown University Hospital (2004)

● MD - Georgetown University School of Medicine (2000)

● BS - Georgetown University (1992)